Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Myoclonus-Epilepsies”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Not applicableAvailableNCT05930223
What this trial is testing

Intravenous VAL-1221 Lafora Expanded Access Protocol

Who this might be right for
Lafora Disease
Parasail, LLC
Not applicableStudy completedNCT00007124
What this trial is testing

Ketogenic Diet in Lafora Disease

Who this might be right for
Lafora Disease
National Institute of Neurological Disorders and Stroke (NINDS) 15
Testing effectiveness (Phase 2)Study completedNCT06051448
What this trial is testing

Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).

Who this might be right for
Mitochondrial DiseasesMitochondrial MyopathiesMitochondrial Encephalomyopathies+2 more
Children's Hospital of Philadelphia 16
Not applicableLooking for participantsNCT06593951
What this trial is testing

Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

Who this might be right for
Progressive Myoclonus Epilepsy Type 1EPM1CSTB-related Disease+5 more
Boston Children's Hospital 200
Not applicableLooking for participantsNCT05554835
What this trial is testing

Global Registry and Natural History Study for Mitochondrial Disorders

Who this might be right for
Mitochondrial DiseasesKearns-Sayre SyndromeMIDD+15 more
LMU Klinikum 6,000
Testing effectiveness (Phase 2)UnknownNCT00639119
What this trial is testing

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type

Who this might be right for
Unverricht-Lundborg Syndrome
University of Turku 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT07084311
What this trial is testing

Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation

Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
n-Lorem Foundation 1
Not applicableStudy completedNCT00006176
What this trial is testing

Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies

Who this might be right for
Familial Dementia With Neuroserpin Inclusion BodiesNervous System Heredodegenerative Disorder
National Human Genome Research Institute (NHGRI) 100
Testing effectiveness (Phase 2)Study completedNCT02023866
What this trial is testing

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

Who this might be right for
Inherited Mitochondrial Disease, Including Leigh Syndrome
Amgen 36
Large-scale testing (Phase 3)Study completedNCT05218655
What this trial is testing

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

Who this might be right for
Inherited Mitochondrial Disease
PTC Therapeutics 101
Testing effectiveness (Phase 2)Ended earlyNCT02473445
What this trial is testing

A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease

Who this might be right for
Mitochondrial Diseases
Amgen 22
Testing effectiveness (Phase 2)Study completedNCT05972954
What this trial is testing

OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)

Who this might be right for
Primary Mitochondrial Disease
Omeicos Therapeutics GmbH 28
Testing effectiveness (Phase 2)Looking for participantsNCT06609889
What this trial is testing

A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease

Who this might be right for
Lafora Disease
Berge Minassian 10
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Large-scale testing (Phase 3)UnknownNCT03351569
What this trial is testing

Intravenous Immunoglobulin for Unverricht-Lundborg Disease.

Who this might be right for
Unverricht-Lundborg Disease
Azienda Socio Sanitaria Territoriale di Mantova 1
Not applicableLooking for participantsNCT01694940
What this trial is testing

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Who this might be right for
Mitochondrial DisordersMitochondrial Genetic DisordersMitochondrial Diseases+2 more
Columbia University 1,000
Large-scale testing (Phase 3)Study completedNCT00357669
What this trial is testing

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Who this might be right for
Unverricht-Lundborg Disease
UCB Pharma SA 50
Not applicableStudy completedNCT03876522
What this trial is testing

Natural History and Functional Status Study of Patients With Lafora Disease

Who this might be right for
Lafora Disease
Ionis Pharmaceuticals, Inc. 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT07221760
What this trial is testing

Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation

Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
n-Lorem Foundation 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT06706388
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation

Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
n-Lorem Foundation 1
Next Page